Project Grant F31DA060032
Award Date
9/18/24
Completion Date
9/17/26
Dollars Obligated
$158K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to design tailored harm reduction strategies to address the escalating drug overdose crisis in the United States. The $2,316,128 award, with a project period from September 15, 2024 to July 31, 2028, will support collaborative efforts with health departments and community partners across six jurisdictions (Rhode Island, Massachusetts, New York...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $722,876 to New York University School of Medicine to conduct a 5-year study characterizing complex opioid use disorder (OUD) care trajectories and outcomes following acute service utilization. The research aims to: 1) characterize real-world OUD treatment trajectories in the year following hospital encounters among treatment-naive...
This Project Grant award, valued at $2,362,500 and effective from July 1, 2025 to June 30, 2029, was provided by the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to overcome policy and regulatory barriers that hinder access to evidence-based harm reduction and treatment services for preventing HIV transmission and overdose among people who use drugs. Key deliverables include: 1) a tool to identify policy...
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $1,607,146 Project Grant to Ndri-Usa Inc., a non-profit organization based in New York City. The grant, titled "TOGETHER AGAINST OVERDOSE: COMMUNITY DEVELOPED TECHNOLOGY TO ENCOURAGE DRUG CHECKING, DISTRIBUTION OF HARM REDUCTION SUPPLIES, AND LINKAGE TO SERVICES", aims to develop technology-based interventions to increase protective behaviors against overdose, such...
This $3,067,394 Project Grant from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a 2-year research study to test a peer-driven "intravention" approach to address unmet harm reduction needs among people who use drugs in two rural Kentucky counties. The project, titled "Engaging People Who Use Drugs in Harm Reduction Service Delivery", aims to reduce the risk of overdose, hepatitis C, skin/soft tissue...
The National Institute on Drug Abuse (NIDA) awarded a $1,994,766 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Cambridge Public Health Commission, doing business as Cambridge Health Alliance (CHA), to assess the causal impact and equity effects of the New York State Medicaid Value-Based Payment (VBP) policy on opioid use disorder (OUD)-related outcomes. The key products and services to be delivered under this 2-year grant, which begins on August 1, 2024,...
This $1,192,612 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The key objectives are to: 1) conduct a systematic assessment of healthcare utilization, HIV prevention services, and medication for OUD (MOUD) using claims and emergency department data; 2) use an evidence-based quality improvement...
This federal Project Grant award of $683,583 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research to estimate the potential impacts of four alternative methadone treatment (MT) policy scenarios in New York State. The project will use an agent-based computer simulation model to analyze how changes to MT access points, such as through OTPs, mobile units, prescribers, and pharmacies, could influence methadone...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), is providing $189,500.00 to the University of Pittsburgh to conduct research on lowering cardiovascular disease (CVD) risk among people with opioid use disorder (OUD). The key objectives of this 5-year project are to: 1) examine the relationship between OUD and time to major adverse cardiovascular events (MACE), 2) determine barriers and...
The National Institute on Drug Abuse (NIDA) awarded a $267,696 Project Grant under CFDA 93.279 - Drug Use and Addiction Research Programs to the University of Massachusetts Lowell (UML), a minority-serving institution, for the project "Enhancing Opportunities for Addiction Research in the Merrimack Valley." The project aims to expand UML's existing Public Health Informatics and Technology (PHIT) program by creating a new PHIT-AR (Addiction Research) track. This will recruit diverse...